| Molecular intercommunication between the complement and coagulation systems U Amara, MA Flierl, D Rittirsch, A Klos, H Chen, B Acker, UB Brückner, ... The Journal of Immunology 185 (9), 5628-5636, 2010 | 824 | 2010 |
| Complement and coagulation: strangers or partners in crime? MM Markiewski, B Nilsson, KN Ekdahl, TE Mollnes, JD Lambris Trends in immunology 28 (4), 184-192, 2007 | 746 | 2007 |
| Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation L Moberg, H Johansson, A Lukinius, C Berne, A Foss, R Källén, Ø Østraat, ... The Lancet 360 (9350), 2039-2045, 2002 | 680 | 2002 |
| Structures of complement component C3 provide insights into the function and evolution of immunity BJC Janssen, EG Huizinga, HCA Raaijmakers, A Roos, MR Daha, ... Nature 437 (7058), 505-511, 2005 | 639 | 2005 |
| The role of complement in biomaterial-induced inflammation B Nilsson, KN Ekdahl, TE Mollnes, JD Lambris Molecular immunology 44 (1-3), 82-94, 2007 | 544 | 2007 |
| Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? W Bennet, B Sundberg, CG Groth, MD Brendel, D Brandhorst, ... Diabetes 48 (10), 1907-1914, 1999 | 541 | 1999 |
| Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes W Bennet, CG Groth, R Larsson, B Nilsson, O Korsgren Upsala journal of medical sciences 105 (2), 125-133, 2000 | 423 | 2000 |
| Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? G Moll, JJ Alm, LC Davies, L von Bahr, N Heldring, L Stenbeck-Funke, ... Stem cells 32 (9), 2430-2442, 2014 | 393 | 2014 |
| Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation H Johansson, A Lukinius, L Moberg, T Lundgren, C Berne, A Foss, ... Diabetes 54 (6), 1755-1762, 2005 | 391 | 2005 |
| Are therapeutic human mesenchymal stromal cells compatible with human blood? G Moll, I Rasmusson-Duprez, L von Bahr, AM Connolly-Andersen, ... Stem cells 30 (7), 1565-1574, 2012 | 374 | 2012 |
| Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran … L Ozmen, KN Ekdahl, G Elgue, R Larsson, O Korsgren, B Nilsson Diabetes 51 (6), 1779-1784, 2002 | 337 | 2002 |
| Psoriasis patients with antibodies to gliadin can be improved by a gluten‐free diet G Michaëlsson, B Gerdén, E Hagforsen, B Nilsson, I Pihl‐Lundin, W Kraaz, ... British Journal of Dermatology 142 (1), 44-51, 2000 | 306 | 2000 |
| Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation S Cabric, J Sanchez, T Lundgren, A Foss, M Felldin, R Kallen, K Salmela, ... Diabetes 56 (8), 2008-2015, 2007 | 287 | 2007 |
| Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency S Bensing, L Brandt, F Tabaroj, O Sjöberg, B Nilsson, A Ekbom, ... Clinical endocrinology 69 (5), 697-704, 2008 | 274 | 2008 |
| DAMAGE TO PORCINE ISLETS OF LANGERHANS AFTER EXPOSURE TO HUMAN BLOOD IN VITRO, OR AFTER INTRAPORTAL TRANSPLANTATION TO CYNOMOLOGUS MONKEYS: Protective Effects of sCR1 and … W Bennet, B Sundberg, T Lundgren, A Tibell, CG Groth, A Richards, ... Transplantation 69 (5), 711-719, 2000 | 249 | 2000 |
| Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention DC Mastellos, D Yancopoulou, P Kokkinos, M Huber‐Lang, ... European journal of clinical investigation 45 (4), 423-440, 2015 | 238 | 2015 |
| Titanium is a highly thrombogenic biomaterial: possible implications for osteogenesis J Hong, J Andersson, KN Ekdahl, G Elgue, N Axen, R Larsson, B Nilsson Thrombosis and haemostasis 82 (07), 58-64, 1999 | 237 | 1999 |
| Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy DC Mastellos, BGPP da Silva, BAL Fonseca, NP Fonseca, ... Clinical Immunology 220, 108598, 2020 | 236 | 2020 |
| Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment B Nilsson, KN Ekdahl, O Korsgren Current opinion in organ transplantation 16 (6), 620-626, 2011 | 230 | 2011 |
| An international serum standard for application in assays to detect human complement activation products G Bergseth, JK Ludviksen, M Kirschfink, PC Giclas, B Nilsson, TE Mollnes Molecular immunology 56 (3), 232-239, 2013 | 229 | 2013 |